যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - tamoxifen citrate - oral tablet - 20mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - tamoxifen citrate - oral tablet - 20mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - tamoxifen citrate - oral tablet - 20mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - tamoxifen citrate - oral tablet - 20mg

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

b & s healthcare - tamoxifen - tablets - 20 milligram

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

b & s healthcare - tamoxifen - tablets - 20 milligram

তাঞ্জানিয়া - ইংরেজি - Tanzania Medicinces & Medical Devices Authority

astrazeneca united kingdom limited, united kingdom - tamoxifen - tablets - 10

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

apotex corp. - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole 1 mg - anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. anastrozole tablets are indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with er-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. hypersensitivity anastrozole tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. observed reactions include anaphylaxis, angioedema, and urticaria [see adverse reactions (6.2)]. risk summary based on findings from animal studies and its mechanism of action, anastrozole may cause fetal harm when administered to a pregnant woman [s

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

golden state medical supply - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole 1 mg - anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. anastrozole tablets are indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with er-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. hypersensitivity anastrozole tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. observed reactions include anaphylaxis, angioedema, and urticaria [see adverse reactions ( 6.2)]. risk summary based on findings from animal studies and its mechanism of action, anastrozole may cause fetal harm when admini

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

dispensing solutions, inc. - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole 1 mg - anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. anastrozole tablets are indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with er-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets. anastrozole may cause fetal harm when administered to a pregnant woman and offers no clinical benefit to premenopausal women with breast cancer. anastrozole is contraindicated in women who are or may become pregnant. there are no adequate and well-controlled studies in pregnant women using anastrozole. if anastrozole is used during pregnancy, or if the patient becomes pregnant while taking this drug,